Hantz Financial Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5K Sell
50
-52
-51% -$5.33K ﹤0.01% 2212
2026
Q1
$11K Buy
102
+76
+292% +$7.24K ﹤0.01% 2023
2025
Q4
$2K Buy
26
+10
+63% +$861 ﹤0.01% 2246
2025
Q3
$1K Buy
16
+4
+33% +$357 ﹤0.01% 2262
2025
Q2
$1K Buy
12
+11
+1,100% +$919 ﹤0.01% 2102
2025
Q1
$0 Buy
+1
New +$93 ﹤0.01% 1861

Other funds holding LMAT

Hantz Financial Services's LMAT Position: Q2 2026 in Review

Hantz Financial Services reduced its LeMaitre Vascular (LMAT) stake by 51% in Q2 2026, selling an estimated $5.33K and leaving 50 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

Hantz Financial Services first reported a position in LMAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $11K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Hantz Financial Services held 50 shares of LeMaitre Vascular worth $5K as of Q2 2026.
  • Hantz Financial Services sold 52 LeMaitre Vascular shares in Q2 2026, an estimated $5.33K.
  • LeMaitre Vascular made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2212 holding.
  • Hantz Financial Services first reported a position in LeMaitre Vascular in Q1 2025 and has held it in 6 quarters since.
  • Hantz Financial Services's LeMaitre Vascular position peaked at $11K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.